Not applicableStudy completedNCT02669966What this trial is testingLive Kidney Donors With Positive Anti-HCV Antibody, But Negative HCV PCRWho this might be right forESRDHepatitis C University of Florida 2
Large-scale testing (Phase 3)Study completedNCT00001729What this trial is testingCombination Drug Therapy for Patients With Hepatitis CWho this might be right forChronic Hepatitis CFibrosisHemolytic Anemia National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 120
Post-approval studies (Phase 4)Ended earlyNCT03207399What this trial is testingLung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA TreatmentWho this might be right forHepatitis C, ChronicLung Transplant Duke University 1
Large-scale testing (Phase 3)Study completedNCT02250807What this trial is testingEfficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus InfectionWho this might be right forChronic Hepatitis CGenotype 4 Chronic Hepatitis C Janssen R&D Ireland 40
Large-scale testing (Phase 3)Study completedNCT00421434What this trial is testingStudy of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis CWho this might be right forChronic Hepatitis C Romark Laboratories L.C. 121
Not applicableStudy completedNCT02562742What this trial is testingUse-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus InfectionWho this might be right forHepatitis C Gilead Sciences 554
Testing effectiveness (Phase 2)Study completedNCT02593162What this trial is testingFaldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus InfectionWho this might be right forHepatitis C Viral InfectionChronic Hepatitis CHepatitis C (HCV)+1 more Trek Therapeutics, PBC 16
Testing effectiveness (Phase 2)Ended earlyNCT01425970What this trial is testingChronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or RibavirinWho this might be right forHepatitis C Bristol-Myers Squibb 210
Post-approval studies (Phase 4)Study completedNCT02482077What this trial is testingSofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected PatientsWho this might be right forChronic Hepatitis C Infection Humanity and Health Research Centre 112
Large-scale testing (Phase 3)Study completedNCT02496078What this trial is testingEvaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b InfectionWho this might be right forHepatitis C Bristol-Myers Squibb 207
Testing effectiveness (Phase 2)UnknownNCT01872936What this trial is testingMiravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus InfectionWho this might be right forHepatitis C, Chronic Santaris Pharma A/S 20
Not applicableStudy completedNCT01453244What this trial is testingPharmacogenomic Research in Korean Patients With Hepatitis CWho this might be right forChronic Hepatitis C Inje University 373
Post-approval studies (Phase 4)Study completedNCT01743521What this trial is testingDAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)Who this might be right forHepatitis C, Chronic Kirby Institute 14
Large-scale testing (Phase 3)Study completedNCT01767116What this trial is testingEvaluate Chronic Hepatitis C Infection in Adults With Genotype 1b InfectionWho this might be right forChronic Hepatitis C Infection AbbVie (prior sponsor, Abbott) 419
Large-scale testing (Phase 3)Study completedNCT00006164What this trial is testingLong Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard TreatmentWho this might be right forChronic Hepatitis cCirrhosis, LiverFibrosis, Liver+1 more National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1,050
Early research (Phase 1)Study completedNCT01704521What this trial is testingViral Kinetics in HCV Clearance in Subjects With HemophiliaWho this might be right forChronic Hepatitis CHemophilia Kenneth Sherman 5
Post-approval studies (Phase 4)Study completedNCT01405027What this trial is testingImpact of Physician Directed Education on Patient Compliance With Hepatitis C TherapyWho this might be right forChronic Hepatitis CGenotype 1 Chronic Liver Disease Foundation 197
Not applicableStudy completedNCT04047680What this trial is testingEGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAsWho this might be right forHepatitis CRenal DiseaseViral Hepatitis C National Taiwan University Hospital 441
Large-scale testing (Phase 3)Study completedNCT01544920What this trial is testingSafety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 737
Testing effectiveness (Phase 2)Study completedNCT01010646What this trial is testingStudy Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4Who this might be right forChronic Hepatitis C ANRS, Emerging Infectious Diseases 84